nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—Trans-sulfuration and one carbon metabolism—PSPH—ocular cancer	0.0494	0.055	CbGpPWpGaD
Raltitrexed—TYMS—G1/S-Specific Transcription—CDC25A—ocular cancer	0.0381	0.0424	CbGpPWpGaD
Raltitrexed—TYMS—G1/S-Specific Transcription—TFDP1—ocular cancer	0.0372	0.0414	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—CDC25A—ocular cancer	0.0224	0.0249	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—TFDP1—ocular cancer	0.0219	0.0244	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDKN2C—ocular cancer	0.018	0.02	CbGpPWpGaD
Raltitrexed—TYMS—G1/S-Specific Transcription—E2F1—ocular cancer	0.0178	0.0198	CbGpPWpGaD
Raltitrexed—Extravasation—Carboplatin—ocular cancer	0.0152	0.151	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—E2F5—ocular cancer	0.015	0.0167	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—E2F4—ocular cancer	0.0147	0.0163	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—MYBL2—ocular cancer	0.0147	0.0163	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—RBL1—ocular cancer	0.0144	0.016	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—E2F2—ocular cancer	0.0144	0.016	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—RBL2—ocular cancer	0.0132	0.0147	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.0125	0.0139	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—RBBP4—ocular cancer	0.0125	0.0139	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—E2F3—ocular cancer	0.0125	0.0139	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDC25A—ocular cancer	0.0119	0.0132	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—TFDP1—ocular cancer	0.0116	0.0129	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.011	0.0122	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.0108	0.0121	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.0108	0.0121	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CCND3—ocular cancer	0.0105	0.0117	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—E2F1—ocular cancer	0.0105	0.0116	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.0103	0.0115	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.0101	0.0112	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—ocular cancer	0.00996	0.0111	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.00916	0.0102	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00914	0.0102	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00898	0.00999	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00898	0.00999	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.0088	0.00979	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.0088	0.00979	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDC25A—ocular cancer	0.00861	0.00958	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—TFDP1—ocular cancer	0.00842	0.00937	CbGpPWpGaD
Raltitrexed—Febrile neutropenia—Dactinomycin—ocular cancer	0.00821	0.0812	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00808	0.00899	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—CRTC1—ocular cancer	0.00801	0.00891	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00763	0.00849	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00763	0.00849	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—RB1—ocular cancer	0.00742	0.00825	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00726	0.00808	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—ID2—ocular cancer	0.00714	0.00794	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.0071	0.00789	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00681	0.00758	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0068	0.00756	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—HDAC1—ocular cancer	0.00674	0.0075	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00667	0.00742	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00643	0.00716	CbGpPWpGaD
Raltitrexed—Necrosis—Dactinomycin—ocular cancer	0.00629	0.0622	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PSPH—ocular cancer	0.00604	0.00672	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00586	0.00652	CbGpPWpGaD
Raltitrexed—Extravasation—Dactinomycin—ocular cancer	0.00566	0.056	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—E2F1—ocular cancer	0.00555	0.00617	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00482	0.00536	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00479	0.00533	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDK2—ocular cancer	0.00478	0.00532	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SAG—ocular cancer	0.00478	0.00532	CbGpPWpGaD
Raltitrexed—Infection—Carboplatin—ocular cancer	0.00471	0.0466	CcSEcCtD
Raltitrexed—Mouth ulceration—Dactinomycin—ocular cancer	0.00446	0.0441	CcSEcCtD
Raltitrexed—Sepsis—Dactinomycin—ocular cancer	0.00429	0.0424	CcSEcCtD
Raltitrexed—FPGS—Disease—E2F5—ocular cancer	0.00423	0.0047	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00416	0.00462	CbGpPWpGaD
Raltitrexed—FPGS—Disease—E2F4—ocular cancer	0.00414	0.00461	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00412	0.00458	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00412	0.00458	CbGpPWpGaD
Raltitrexed—FPGS—Disease—RBL1—ocular cancer	0.00406	0.00452	CbGpPWpGaD
Raltitrexed—FPGS—Disease—RPL39—ocular cancer	0.00406	0.00452	CbGpPWpGaD
Raltitrexed—Pain—Carboplatin—ocular cancer	0.00406	0.0401	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00404	0.00449	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—E2F1—ocular cancer	0.00402	0.00448	CbGpPWpGaD
Raltitrexed—Hepatic failure—Dactinomycin—ocular cancer	0.00399	0.0394	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—RB1—ocular cancer	0.00393	0.00437	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00393	0.00437	CbGpPWpGaD
Raltitrexed—Body temperature increased—Carboplatin—ocular cancer	0.00375	0.0371	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00369	0.00411	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—ocular cancer	0.00363	0.00404	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2C—ocular cancer	0.00361	0.00402	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—GNA11—ocular cancer	0.00358	0.00398	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDK2—ocular cancer	0.00347	0.00386	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00342	0.0038	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00339	0.00377	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00336	0.00374	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—GNAQ—ocular cancer	0.00333	0.0037	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00329	0.00366	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00329	0.00366	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TFDP1—ocular cancer	0.00327	0.00364	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00323	0.00359	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00323	0.00359	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1B—ocular cancer	0.00306	0.0034	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—E2F5—ocular cancer	0.003	0.00334	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—HDAC1—ocular cancer	0.003	0.00333	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00296	0.0033	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—E2F4—ocular cancer	0.00294	0.00327	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYBL2—ocular cancer	0.00294	0.00327	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00292	0.00325	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00291	0.00324	CbGpPWpGaD
Raltitrexed—Neutropenia—Dactinomycin—ocular cancer	0.0029	0.0286	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—E2F2—ocular cancer	0.00289	0.00321	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RBL1—ocular cancer	0.00289	0.00321	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—RB1—ocular cancer	0.00285	0.00317	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1A—ocular cancer	0.00282	0.00314	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—E2F3—ocular cancer	0.0028	0.00311	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.0028	0.00311	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.0028	0.00311	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00276	0.00308	CbGpPWpGaD
Raltitrexed—Stomatitis—Dactinomycin—ocular cancer	0.00269	0.0266	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—EP300—ocular cancer	0.00269	0.00299	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00266	0.00296	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00266	0.00296	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RBL2—ocular cancer	0.00265	0.00295	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.0026	0.00289	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAML2—ocular cancer	0.0026	0.00289	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00257	0.00286	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00254	0.00282	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—E2F3—ocular cancer	0.0025	0.00278	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RBBP4—ocular cancer	0.0025	0.00278	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00245	0.00273	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RB1—ocular cancer	0.0024	0.00267	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDC25A—ocular cancer	0.00238	0.00265	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00236	0.00262	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—MYC—ocular cancer	0.00234	0.0026	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TFDP1—ocular cancer	0.00233	0.00259	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDKN1B—ocular cancer	0.00222	0.00247	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00222	0.00246	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PSPH—ocular cancer	0.0022	0.00245	CbGpPWpGaD
Raltitrexed—Alopecia—Dactinomycin—ocular cancer	0.00219	0.0217	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CCND3—ocular cancer	0.00211	0.00235	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00209	0.00233	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDKN1A—ocular cancer	0.00205	0.00228	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00203	0.00226	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—CDK4—ocular cancer	0.00201	0.00224	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Dactinomycin—ocular cancer	0.002	0.0198	CcSEcCtD
Raltitrexed—Anaemia—Dactinomycin—ocular cancer	0.002	0.0197	CcSEcCtD
Raltitrexed—Malaise—Dactinomycin—ocular cancer	0.00195	0.0193	CcSEcCtD
Raltitrexed—Leukopenia—Dactinomycin—ocular cancer	0.00193	0.0191	CcSEcCtD
Raltitrexed—FPGS—Disease—HDAC1—ocular cancer	0.0019	0.00212	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GNA11—ocular cancer	0.0019	0.00211	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00187	0.00208	CbGpPWpGaD
Raltitrexed—Discomfort—Dactinomycin—ocular cancer	0.00182	0.018	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00178	0.00199	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GNAQ—ocular cancer	0.00177	0.00197	CbGpPWpGaD
Raltitrexed—Oedema—Dactinomycin—ocular cancer	0.00176	0.0174	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00176	0.00196	CbGpPWpGaD
Raltitrexed—Infection—Dactinomycin—ocular cancer	0.00175	0.0173	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00173	0.00192	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Dactinomycin—ocular cancer	0.00172	0.0171	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN2B—ocular cancer	0.00171	0.0019	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—MYC—ocular cancer	0.0017	0.00189	CbGpPWpGaD
Raltitrexed—Anorexia—Dactinomycin—ocular cancer	0.00168	0.0166	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00167	0.00186	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.00161	0.0159	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDK6—ocular cancer	0.00157	0.00175	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00155	0.00173	CbGpPWpGaD
Raltitrexed—Decreased appetite—Dactinomycin—ocular cancer	0.00153	0.0151	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00151	0.00168	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00151	0.00168	CbGpPWpGaD
Raltitrexed—Pain—Dactinomycin—ocular cancer	0.00151	0.0149	CcSEcCtD
Raltitrexed—Feeling abnormal—Dactinomycin—ocular cancer	0.00145	0.0144	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Dactinomycin—ocular cancer	0.00144	0.0142	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00143	0.00159	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00142	0.00158	CbGpPWpGaD
Raltitrexed—Body temperature increased—Dactinomycin—ocular cancer	0.00139	0.0138	CcSEcCtD
Raltitrexed—Abdominal pain—Dactinomycin—ocular cancer	0.00139	0.0138	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00135	0.00151	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00135	0.0015	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—HDAC1—ocular cancer	0.00135	0.0015	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND2—ocular cancer	0.00135	0.0015	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00131	0.00146	CbGpPWpGaD
Raltitrexed—Asthenia—Dactinomycin—ocular cancer	0.00126	0.0125	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00124	0.00138	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00124	0.00138	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2B—ocular cancer	0.00121	0.00135	CbGpPWpGaD
Raltitrexed—Diarrhoea—Dactinomycin—ocular cancer	0.00121	0.0119	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—EP300—ocular cancer	0.00119	0.00133	CbGpPWpGaD
Raltitrexed—Vomiting—Dactinomycin—ocular cancer	0.00112	0.0111	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—E2F1—ocular cancer	0.00111	0.00124	CbGpPWpGaD
Raltitrexed—Rash—Dactinomycin—ocular cancer	0.00111	0.011	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00108	0.00121	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00108	0.0012	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00107	0.00119	CbGpPWpGaD
Raltitrexed—Nausea—Dactinomycin—ocular cancer	0.00105	0.0103	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00101	0.00113	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDK2—ocular cancer	0.000959	0.00107	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MDM2—ocular cancer	0.000946	0.00105	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDK4—ocular cancer	0.000906	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000891	0.000991	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	0.000881	0.000981	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1B—ocular cancer	0.000864	0.000961	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—ocular cancer	0.000855	0.000951	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1A—ocular cancer	0.000797	0.000887	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RB1—ocular cancer	0.000788	0.000877	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EP300—ocular cancer	0.000758	0.000844	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000752	0.000837	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GNA11—ocular cancer	0.000693	0.000771	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000686	0.000763	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MDM2—ocular cancer	0.000672	0.000748	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—ocular cancer	0.000661	0.000735	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—ocular cancer	0.000659	0.000733	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000655	0.000728	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GNAQ—ocular cancer	0.000644	0.000717	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—EP300—ocular cancer	0.000635	0.000707	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000633	0.000705	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—ocular cancer	0.000614	0.000683	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	0.000603	0.00067	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—ocular cancer	0.000585	0.000651	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1A—ocular cancer	0.000566	0.00063	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—EP300—ocular cancer	0.000539	0.000599	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	0.000525	0.000584	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—ocular cancer	0.000519	0.000577	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—ocular cancer	0.00047	0.000522	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—ocular cancer	0.000458	0.00051	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—ocular cancer	0.000386	0.000429	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—ocular cancer	0.000384	0.000427	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—EP300—ocular cancer	0.000231	0.000258	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—ocular cancer	0.00014	0.000156	CbGpPWpGaD
